Procter & Gamble (NYSE:PG) Price Target Lowered to $175.00 at Raymond James Financial

Procter & Gamble (NYSE:PGFree Report) had its target price reduced by Raymond James Financial from $185.00 to $175.00 in a research report released on Monday morning,Benzinga reports. They currently have an outperform rating on the stock.

PG has been the topic of a number of other reports. Evercore ISI reissued an “in-line” rating and issued a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. UBS Group cut their price target on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. Barclays cut their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 1st. Berenberg Bank boosted their price target on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a report on Wednesday, September 17th. Finally, BNP Paribas reissued an “outperform” rating and issued a $177.00 price target on shares of Procter & Gamble in a report on Friday, August 15th. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $171.68.

View Our Latest Stock Report on Procter & Gamble

Procter & Gamble Price Performance

PG opened at $151.98 on Monday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The company has a market capitalization of $355.72 billion, a price-to-earnings ratio of 23.35, a P/E/G ratio of 4.02 and a beta of 0.36. The firm’s fifty day moving average price is $154.86 and its two-hundred day moving average price is $158.59. Procter & Gamble has a 1 year low of $146.96 and a 1 year high of $180.43.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.42 by $0.06. The firm had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business’s revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, analysts anticipate that Procter & Gamble will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Friday, October 24th will be issued a dividend of $1.0568 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 annualized dividend and a yield of 2.8%. Procter & Gamble’s dividend payout ratio is 64.98%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CFO Andre Schulten sold 4,252 shares of the company’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $647,281.96. Following the sale, the chief financial officer directly owned 53,992 shares of the company’s stock, valued at $8,219,202.16. This represents a 7.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Shailesh Jejurikar sold 3,986 shares of the company’s stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $606,788.78. Following the sale, the chief operating officer directly owned 46,899 shares in the company, valued at approximately $7,139,434.77. This trade represents a 7.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 149,763 shares of company stock valued at $23,421,279. Insiders own 0.20% of the company’s stock.

Institutional Investors Weigh In On Procter & Gamble

A number of institutional investors and hedge funds have recently modified their holdings of PG. Brighton Jones LLC lifted its holdings in shares of Procter & Gamble by 51.5% in the fourth quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock worth $6,717,000 after buying an additional 13,617 shares in the last quarter. Taylor Financial Group Inc. lifted its holdings in shares of Procter & Gamble by 10.6% in the first quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock worth $493,000 after buying an additional 277 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of Procter & Gamble by 22.4% in the first quarter. GAMMA Investing LLC now owns 46,658 shares of the company’s stock worth $7,951,000 after buying an additional 8,537 shares in the last quarter. Summit Wealth Group LLC lifted its holdings in shares of Procter & Gamble by 11.2% in the first quarter. Summit Wealth Group LLC now owns 7,437 shares of the company’s stock worth $1,267,000 after buying an additional 752 shares in the last quarter. Finally, North Point Portfolio Managers Corp OH lifted its holdings in shares of Procter & Gamble by 138.1% in the first quarter. North Point Portfolio Managers Corp OH now owns 5,871 shares of the company’s stock worth $1,001,000 after buying an additional 3,405 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Company Profile

(Get Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Read More

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.